Julia Boland1,2,3, Darius Shahbazi2,4, Ryan Stevenson2, Shahin Shahbazi1,2. 1. Drexel University College of Medicine, Philadelphia, PA. 2. South Sacramento Medical Center, Sacramento, CA. 3. George Washington University Hospital, Washington, DC. 4. Creighton University, Omaha, NE.
Abstract
INTRODUCTION: Birt-Hogg-Dubé syndrome and hereditary paraganglioma-pheochromocytoma syndrome are rare genetic cancer syndromes that predispose patients to renal neoplasia. We report a case of a 25-year-old man with both Birt-Hogg-Dubé syndrome and hereditary paraganglioma-pheochromocytoma syndrome who presented with painless gross hematuria and was found to have metastatic clear cell renal carcinoma. CASE PRESENTATION: A previously healthy, 25-year-old man presented to his outpatient primary care physician with painless gross hematuria. Urinalysis results demonstrated hemoglobinuria, and serum chemistry results demonstrated a creatinine level of 1.61 mg/dL (baseline of 0.96 mg/dL). A computed tomography scan showed that the patient had a left renal mass, renal vein thrombosis with inferior vena cava extension, and nodal and hepatic metastasis. Biopsy specimens of the left renal mass and liver demonstrated clear cell carcinoma. The patient underwent cytoreductive nephrectomy, caval thrombectomy, and partial colectomy with reanastomosis. He received palliative therapy with 1 mg/kg of ipilimumab and 3 mg/kg of nivolumab for 4 cycles. CONCLUSION: To our knowledge, this is the first known case report to date documenting a patient with concurrent Birt-Hogg-Dubé syndrome and hereditary paraganglioma-pheochromocytoma syndrome. This case demonstrates the exceptionally young presentation of metastatic renal cell carcinoma with this genotype.
INTRODUCTION: Birt-Hogg-Dubé syndrome and hereditary paraganglioma-pheochromocytoma syndrome are rare genetic cancer syndromes that predispose patients to renal neoplasia. We report a case of a 25-year-old man with both Birt-Hogg-Dubé syndrome and hereditary paraganglioma-pheochromocytoma syndrome who presented with painless gross hematuria and was found to have metastatic clear cell renal carcinoma. CASE PRESENTATION: A previously healthy, 25-year-old man presented to his outpatient primary care physician with painless gross hematuria. Urinalysis results demonstrated hemoglobinuria, and serum chemistry results demonstrated a creatinine level of 1.61 mg/dL (baseline of 0.96 mg/dL). A computed tomography scan showed that the patient had a left renal mass, renal vein thrombosis with inferior vena cava extension, and nodal and hepatic metastasis. Biopsy specimens of the left renal mass and liver demonstrated clear cell carcinoma. The patient underwent cytoreductive nephrectomy, caval thrombectomy, and partial colectomy with reanastomosis. He received palliative therapy with 1 mg/kg of ipilimumab and 3 mg/kg of nivolumab for 4 cycles. CONCLUSION: To our knowledge, this is the first known case report to date documenting a patient with concurrent Birt-Hogg-Dubé syndrome and hereditary paraganglioma-pheochromocytoma syndrome. This case demonstrates the exceptionally young presentation of metastatic renal cell carcinoma with this genotype.
Authors: Christian P Pavlovich; Robert L Grubb; Kathleen Hurley; Gladys M Glenn; Jorge Toro; Laura S Schmidt; Carlos Torres-Cabala; Maria J Merino; Berton Zbar; Peter Choyke; McClellan M Walther; W Marston Linehan Journal: J Urol Date: 2005-05 Impact factor: 7.450
Authors: Christian P Pavlovich; McClellan M Walther; Robin A Eyler; Stephen M Hewitt; Berton Zbar; W Marston Linehan; Maria J Merino Journal: Am J Surg Pathol Date: 2002-12 Impact factor: 6.394
Authors: L S Schmidt; M B Warren; M L Nickerson; G Weirich; V Matrosova; J R Toro; M L Turner; P Duray; M Merino; S Hewitt; C P Pavlovich; G Glenn; C R Greenberg; W M Linehan; B Zbar Journal: Am J Hum Genet Date: 2001-08-30 Impact factor: 11.025
Authors: Fred H Menko; Maurice A M van Steensel; Sophie Giraud; Lennart Friis-Hansen; Stéphane Richard; Silvana Ungari; Magnus Nordenskjöld; Thomas Vo Hansen; John Solly; Eamonn R Maher Journal: Lancet Oncol Date: 2009-12 Impact factor: 41.316
Authors: Christopher J Ricketts; Julia R Forman; Eleanor Rattenberry; Nicola Bradshaw; Fiona Lalloo; Louise Izatt; Trevor R Cole; Ruth Armstrong; V K Ajith Kumar; Patrick J Morrison; A Brew Atkinson; Fiona Douglas; Steve G Ball; Jackie Cook; Umasuthan Srirangalingam; Pip Killick; Gail Kirby; Simon Aylwin; Emma R Woodward; D Gareth R Evans; Shirley V Hodgson; Vicky Murday; Shern L Chew; John M Connell; Tom L Blundell; Fiona Macdonald; Eamonn R Maher Journal: Hum Mutat Date: 2010-01 Impact factor: 4.878
Authors: Paul C Johannesma; Irma van de Beek; Tijmen J W T van der Wel; Rinze Reinhard; Lawrence Rozendaal; Theo M Starink; Jan Hein T M van Waesberghe; Simon Horenblas; Hans J J P Gille; Marianne A Jonker; Hanne E J Meijers-Heijboer; Pieter E Postmus; Arjan C Houweling; Jeroen R A van Moorselaar Journal: PLoS One Date: 2019-03-07 Impact factor: 3.240